60174797

  • Upload
    serubim

  • View
    216

  • Download
    0

Embed Size (px)

Citation preview

  • 7/28/2019 60174797

    1/5

    BRIEF REPORT

    What are we doing about septic arthritis? A survey

    of UK-based rheumatologists and orthopedic surgeons

    Usman Butt & Maame Amissah-Arthur &

    Fazal Khattak& Chris F. Elsworth

    Received: 4 October 2010 /Revised: 9 December 2010 /Accepted: 13 December 2010 /Published online: 11 January 2011# Clinical Rheumatology 2011

    Abstract This study aims to determine the current practices

    and beliefs of United Kingdom (UK)-based rheumatologistsand orthopedic surgeons (OS) in managing septic arthritis

    (SA) and to determine awareness levels of national guidance.

    Two-hundred OS and 200 rheumatologists were sent a link to

    a web-based survey tool via email. Questions posed related to

    the management of SA, including the respondents views on

    antibiotic therapy, joint drainage, which specialty should

    manage these cases, and also the clinicians evidence base.

    There were 354 functioning addresses with 182 responses

    (51%). One hundred fifty-one (77 OS, 74 rheumatologists)

    (43%) responses were complete and included for analysis.

    Eighty percent of rheumatologists and 82% of OS recom-

    mended 6-weeks total antibiotic therapy. Seventy-three

    percent in each group recommended 12 weeks intravenous

    therapy initially followed by oral continuation therapy. In

    patients at risk of methicillin-resistantStaphylococcus aureus

    (MRSA), 25% rheumatologists and 14% OS would ensure

    MRSA cover. Seventy-seven percent of rheumatologists and

    66% of OS recommended surgical joint drainage; 22% and

    27%, respectively, recommended repeated closed needle

    aspiration as their chosen method of joint drainage. Sixty-

    six percent of rheumatologists and 65% of OS believed OS

    should manage SA. Twenty-three percent of rheumatologists

    and 22% of OS quoted published guidance as their main

    evidence base in the treatment of SA. Only 24% of

    rheumatologists and 34% of OS quoted British Society of

    Rheumatology (BSR) guidance when asked if they wereaware of any guidelines. Views of rheumatologists and OS

    are not that dissimilar in managing SA. Surprisingly,

    rheumatologists are more aggressive regarding the recom-

    mendation for surgical joint drainage. Within both groups,

    significant variation in management principles exists often

    discrepant to recommendations laid out by the BSR. There

    are poor awareness levels of the BSR guidelines.

    Keywords Infective arthritis . Joint infection . Septic

    arthritis . Survey

    Introduction

    Septic arthritis (SA), though relatively uncommon, is a

    clinical emergency which should be identified early and

    treated promptly, as it can lead to rapid and irreversible

    articular cartilage destruction. It is associated with a

    significant mortality risk with reported figures as high as

    11% for monoarticular sepsis and 50% in polyarticular

    cases [1, 2]. Given the varied causes of a hot swollen joint,

    obtaining a firm diagnosis can often be difficult even for

    experienced clinicians. Early referral for specialist assess-

    ment and management is imperative if SA is suspected.

    This is often carried out by rheumatologists or orthopedic

    surgeons (OS) depending upon local policies.

    To facilitate standardized care, guidelines for the

    management of hot swollen joints were introduced in

    2006 by a multi-disciplinary working party set up by the

    British Society for Rheumatology (BSR), which comprised

    of the British Orthopaedic Association (BOA), the British

    Society for Antimicrobial Chemotherapy, and the Royal

    College of General Practitioners [3]. These laid out clear

    U. Butt (*) : C. F. Elsworth

    Pennine Acute Trust, Royal Oldham Hospital,

    Rochdale Road,

    Oldham OL1 2JH, UK

    e-mail: [email protected]

    M. Amissah-Arthur: F. Khattak

    Sandwell and West Birmingham Hospitals NHS Trust,

    Birmingham, UK

    Clin Rheumatol (2011) 30:707710

    DOI 10.1007/s10067-010-1672-3

    http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-
  • 7/28/2019 60174797

    2/5

    instructions for the assessment and management of SA.

    Diagnostic recommendations stated that the affected joint

    must be aspirated and synovial fluid sent for analysis

    (including crystals) and culture, before commencing anti-

    biotics where possible. Gram-stain analysis of synovial

    fluid gives quick results and can facilitate early, targeted

    antibiotic therapy. Specificity approaches 100% for this

    test, however sensitivity is in the region of 5070% makinga negative result particularly unreliable [2, 4]. Where

    clinical suspicion is high, it is imperative to treat it as

    infection.

    Guidelines stipulate that aspiration of the joint should

    be followed by antibiotic administration, and complete

    drainage of pus by means of arthroscopic washout or

    closed needle aspiration is regarded essential. Arthrotomy

    was not considered in the guidelines. The working party

    acknowledged insufficient evidence in the literature to

    suggest any additional benefit of surgical drainage over

    closed needle aspiration in the majority of cases and

    deemed either as acceptable. However, in cases ofunsatisfactory response to medical management, the

    presence of thick, inspissated pus, or hip involvement,

    surgical intervention is required [3].

    There is a scarcity of evidence to guide antibiotic

    choice and duration. There are no randomized controlled

    trials in the literature. It is acknowledged that local

    policies may be developed, but as a general guide,

    flucloxacillin is first choice with or without the addition

    gentamicin, as 60% or more of cases of SA are due to

    Staphylococcus organisms. Clindamycin or cephalosporins

    (2nd or 3 rd generation) are used in cases of penicillin

    allergy. Where there is a risk of gram-negative organisms,

    cephalosporins are advised. If there is a risk of methicillin-

    resistant Staphylococcus aureus (MRSA) (known case,

    recent inpatient, nursing home resident, leg ulcers or

    catheters, or other risk factors determined locally), then

    vancomycin is advised in addition to cephalosporins.

    Discussion with a microbiologist is recommended for

    complex cases such as those involving intravenous drug

    users or intensive care patients [3].

    Despite the lack of solid evidence for certain aspects

    in the treatment of SA, the BSR guidelines provided a

    welcome step toward standardizing care for patients with

    SA. Four years on from this publication, we conducted a

    survey to determine the current trends and beliefs

    surrounding the management of SA among OS and

    rheumatologists. We hypothesized that there would not

    only be a consistent divide in management, but also

    reticence from the surgical community to acknowledge

    the option of non-surgical management. In addition, we

    sought to ascertain the evidence base for the clinicians

    management principles and assess awareness levels of

    the BSR guidelines.

    Method

    Two-hundred consultant OS and 200 rheumatologists were

    identified using the BOA and the BSR handbooks,

    respectively. A link to an online questionnaire, using a

    web-based survey tool [5], was emailed to the doctors with

    a covering letter from the first two authors in three phases

    (November 2009, December 2009, and February 2010).The doctors were asked to confirm their grade and specialty

    and whether they routinely managed cases of SA. A short

    clinical scenario was presented of a patient with a strong

    working diagnosis of a septic knee joint. Initial questioning

    focused on early, commonly encountered, management

    decisions in cases of presumed SA. Respondents were

    asked about choice of antibiotic therapy including their

    views on MRSA cover. Views on the need and methods of

    joint drainage were determined, and also whether the

    clinicians management would alter on the basis of a

    negative rather than positive gram-stain result. The final

    section of questioning addressed the evidence base for theclinicians practice, including their knowledge of any

    published guidelines. Beliefs relating to the role for surgery

    and which hospital specialty should manage SA were also

    enquired about.

    Results

    From 400 emails sent out in phase 1, a total of 46 (23

    rheumatology and 23 orthopedic) addresses were non-

    functional, leaving a sample of 354. By the end of phase

    3, there were 182 responses (51%). Of these, 151 (43%)

    completed the survey in its entirety and were included for

    analysis77 (51%) were OS and 74 were rheumatologists

    (49%).

    Antibiotic therapy

    The duration of antibiotic cover the respondents would

    advise varied, but the majority of doctors recommended

    at least 12 weeks of intravenous therapy, or would

    consult a microbiologist for advice (Fig. 1). Regarding

    total duration of antibiotic treatment (including oral

    continuation therapy), most would continue for a mini-

    mum of 6 weeks (82% OS and 80% rheumatologists); 6%

    OS and 14% rheumatologists advised a total of 4 weeks

    antibiotic therapy. A small proportion of each group stated

    some other duration (4% OS answered 2 weeks only); 4%

    OS would rely on microbiology advice; 4% OS and 7%

    rheumatologists would continue until inflammatory

    markers had normalized.

    None of the OS questioned would routinely cover for

    MRSA infection, compared with 4 (6%) rheumatologists

    708 Clin Rheumatol (2011) 30:707710

    http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-
  • 7/28/2019 60174797

    3/5

    who would. Eleven (14%) OS compared with 19 (25%)

    rheumatologists said they would cover if there were risk

    factors for MRSA. Microbiology advice must always besought when there is uncertainty or an unusual organism is

    being treated.

    Additional measures (Joint drainage)

    In a presumed case of SA, 50 (65%) OS and 56 (76%)

    rheumatologists would recommend an arthroscopic joint

    washout as their preferred method of joint drainage, with 21

    (27%) OS and 16 (22%) rheumatologists recommending

    closed needle aspiration repeated as required. Three OS and

    one rheumatologist recommended open joint washout. Three

    OS and one rheumatologist would use antibiotics alone.

    Fifty-three (69%) OS reported there would be no change

    in their management plan if the gram-stain result was

    negative, whereas 24 (31%) OS said that their management

    would alter mainly by deferring surgery. Sixteen (22%)

    rheumatologists would alter their management in light of a

    negative gram-stain result most commonly by deferring

    surgery; 58 (78%) rheumatologists would not change their

    management plan.

    Evidence base

    Less than one quarter of either rheumatologists or OS

    quoted published guidelines as the main evidence base for

    their practice (22% OS and 23% rheumatologists). The

    remaining doctors across both specialties answered that

    their practice was primarily based on personal experience,

    senior recommendation or general reading. When asked if

    they were aware of any published guidelines and asked to

    say what the source of these were, only 34% of OS and

    24% of rheumatologists quoted the BSR guidelines.

    Discussion

    Regarding empirical antibiotics, rheumatologists were more

    likely to provide MRSA cover, though a sizeable propor-

    tion of each group, not unsurprisingly, said they would be

    guided by microbiology advice. MRSA is increasingly

    being recognized as the causative organism in a range of

    invasive infections, both community and hospital acquired[6, 7].

    A large amount of current literature and commentary on

    SA, written mainly by rheumatologists, would suggest no

    additional benefit of surgery in uncomplicated cases of a

    septic knee [1, 2, 812]. It was therefore interesting to find

    the overwhelming majority of rheumatologists (76%)

    recommended arthroscopic joint washout as the method of

    choice for joint drainage, an even larger proportion than the

    OS surveyed (65%). Furthermore, a smaller proportion of

    rheumatologists than OS (22% vs 27%) recommended

    closed needle aspirations repeated as required. The

    expected observation that OS would be more likely torecommend that surgery was not realized. One prospective

    observational study of 75 patients found that 83% of

    patients undergoing surgical management were orthopedic

    patients compared with only 17% patients on non-surgical

    wards [11]. This sample did however include prosthetic

    joint infections and hip infections, which, as previously

    mentioned, are inevitably managed surgically. As such,

    any inference regarding management preferences between

    different specialists is difficult to make from that

    particular study.

    To further re-enforce the notion that surgery is not an

    inevitability whilst under the care of an OS, and in keeping

    with the question regarding joint drainage, a larger

    proportion of rheumatologists (50% vs 43%, respectively)

    agreed with the position that non-surgical management had

    no place in the management of cases of SA such as that

    described. Most rheumatologists (66%) also suggested

    orthopedics was the most appropriate specialty to manage

    such cases. Interestingly, these views were virtually

    mirrored by the OS (65%).

    As regards antibiotic duration, in line with guidance, the

    vast majority of OS and rheumatologists would use

    intravenous antibiotics for a minimum of 12 weeks and

    continue with oral antibiotics for a minimum of 6 weeks in

    total.

    Less than one quarter of both OS and rheumatologists

    quoted published guidelines as their primary evidence base

    in managing SA. The most likely reason for this is the

    relatively low levels of awareness of the BSR guidelines in

    our sample. Only 34% OS and 24% rheumatologists were

    aware of the guidance (43% and 40% respectively were

    aware of any published guidance at all). Likewise, in a

    survey of trainee doctors conducted by Ravindran et al.,

    Fig. 1 Duration of initial intravenous antibiotic therapy

    Clin Rheumatol (2011) 30:707710 709

    http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-
  • 7/28/2019 60174797

    4/5

    only 42% (13 of 31 surveyed) were aware of the BSR

    guidelines [13]. The poor awareness level they reported was

    exemplified by a lack of compliance with the guidelines in

    their own trust audit, the findings of which were presented

    in the same article. Other similar audits have been carried

    out which likewise show variable and often poor adherence

    to the BSR guidelines with a general lack of awareness of

    their existence [1418].Useful recommendations from these audits include the

    introduction of a hot joint pack containing a management

    algorithm and specimen bottles for patients presenting with

    a hot swollen joint [16]. At the very least, this could

    improve the diagnosis and early management of infected

    joints along with the recognition amongst doctors that

    guidance exists for this condition. Ravindran et al.

    suggested that clinical audits themselves provide a vehicle

    for wider dissemination of the BSR guidance and could

    help in optimizing care [13].

    Contrary to our initial hypothesis, the views of rheuma-

    tologists and OS are not that dissimilar. If anything,rheumatologists were more aggressive regarding the rec-

    ommendation for surgical joint drainage. However, it is

    apparent that within both groups, significant variation in

    management principles exists which is discrepant to the

    recommendations laid out in the BSR guidelines. The

    guidelines were comprehensive and produced by experts,

    but nevertheless a poor evidence base was acknowledged in

    the document for certain aspects in the management of SA.

    This coupled with poor awareness levels offers some

    explanation for variable adherence to the guidance. A

    stronger body of evidence in the form of a large-scale

    randomized controlled trial with cost-analysis would ulti-

    mately help to reduce variation in treatment strategy that

    continues to be based largely on personal preferences. It is

    recognized that these trials are logistically difficult to carry

    out and so in the absence of such, wider dissemination of

    current guidance is an essential measure to ensure

    standardization and appropriate care. Publication of

    guidance in journals accessed by the many specialties

    involved in caring for those with SA, particularly

    including microbiologists, rheumatologists, OS, emergency

    and general physicians, is paramount. Regular multi-

    disciplinary audits and presentations at both local and

    national levels would ensure that this important condition

    receives appropriate attention and consideration by both

    policy makers and those involved at the frontline of

    patient care across all levels of seniority.

    Disclosures None.

    References

    1. Gupta MN, Sturrock RD, Field M (2001) A prospective 2-yearstudy of 75 patients with adult-onset septic arthritis. Rheumatol

    (Oxf) 40:2430

    2. Mathews JM, Weston VC, Jones A, Field M, Coakley G (2010)

    Bacterial septic arthritis in adults. Lancet 375:846855

    3. Coakley G, Mathews C, Field M et al (2006) BSR & BHPR,

    BOA, RCGP and BSAC guidelines for management of the hot

    swollen joint in adults. Rheumatol (Oxf) 45:10391041

    4. Brannan SR, Jerrard DA (2006) Synovial fluid analysis. J Emerg

    Med 30:331339

    5. Ryan Finley. http://www.SurveyMonkey.com , Portland, OR, USA

    6. Frazee BW, Fee C, Lambert L (2009) How common is MRSA in

    adult septic arthritis. Ann Emerg Med 54:695700

    7. Ross JJ, Davidson L (2005) Methicillin-resistant Staphylococcus

    aureus septic arthritis: an emerging clinical syndrome. Rheumatol

    (Oxf) 44:119711988. Ravindran V, Logan I, Bourke BE (2009) Medical vs surgical

    management for the native joint in septic arthritis: a 6-year,

    single UK academic centre experience. Rheumatol (Oxf)

    48:13201322

    9. Goldenberg DL, Brandt KD, Cohen AS, Cathcart ES (1975)

    Treatment of septic arthritis: comparison of needle aspiration and

    surgery as initial modes of joint drainage. Arthritis Rheum 18:83

    90

    10. Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M

    (1999) Clinical features and outcome of septic arthritis in a single

    UK Health District 19821991. Ann Rheum Dis 58:214219

    11. Cooper C, Cawley MI (1986) Bacterial Arthritis in an English

    health district: a 10 year review. Ann Rheum Dis 45:458463

    12. Sammer DM, Shin AY (2009) Comparison of arthroscopic and

    open treatment of septic arthritis of the wrist. J Bone Joint SurgAm 91:13871393

    13. Ravindran V, Logan I, Bourke BE (2008) Septic arthritis: clinical

    audits would help optimise the management. Clin Rheumatol

    27:15651567

    14. Al-Mossawi M (2010) Clinical audit of the management of

    suspected septic arthritis in the emergency department. Rheumatol

    (Oxf) 49(Suppl 1):i67

    15. Lim CSE, Low ST, Joshi N, Walton T (2010) Acute monoarthritis:

    a clinical audit in a district general hospital. Rheumatol (Oxf) 49

    (Suppl 1):i73

    16. Menezes BF, Cooke RP, Estrach C et al (2010) A hot joint pack

    improves the management of the acute hot joint. Rheumatol (Oxf)

    48(Suppl 1):i113

    17. Shahbaz-Samavi M (2009) An audit of adults with hot swollen

    joints presenting to Salford Royal Accident and EmergencyDepartment. Rheumatol (Oxf) 48(Suppl 1):i150

    18. Wong Y, Morgan G, Young L (2009) Management of septic

    arthritis at a UK district general hospital. Rheumatol (Oxf) 48

    (Suppl 1):i153

    710 Clin Rheumatol (2011) 30:707710

    http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-http://www.surveymonkey.com/http://www.surveymonkey.com/http://-/?-http://-/?-http://-/?-http://-/?-http://-/?-
  • 7/28/2019 60174797

    5/5

    Copyright of Clinical Rheumatology is the property of Springer Science & Business Media B.V. and its content

    may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express

    written permission. However, users may print, download, or email articles for individual use.